CUREDM
Updated 36 days ago
1201 N. Market St., Suite 701 Wilmington, DE 19801
CureDM, Inc. is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.
Also known as: CureDM Group Holdings, LLC, CureDM, Inc.